Literature DB >> 29477262

Predictive value of Type D personality for impaired endothelial function in patients with coronary artery disease.

Johan Denollet1, Romy A van Felius2, Paul Lodder2, Paula M Mommersteeg2, Inge Goovaerts3, Nadine Possemiers3, Luc Vanhees4, Paul Beckers3, Nele Pattyn4, Emeline M Van Craenenbroeck3.   

Abstract

BACKGROUND: Type D personality (high negative affectivity and social inhibition) is associated with cardiovascular events and coronary plaque severity. Whether Type D is also related to functional vasomotion abnormalities is unknown. We examined concurrent and predictive associations of Type D with endothelial dysfunction in patients with coronary artery disease (CAD).
METHODS: At baseline, 180 CAD patients (90% men; M = 58.0 years) completed Type D (DS14) and depression scales, and entered a 12-week exercise program. Flow-mediated dilation (FMD) of the brachial artery and circulating CD34+/KDR+/CD45+dim endothelial progenitor cells (EPCs) were assessed at baseline, 3 months, and 12 months. Logistic regression and linear mixed models were used to analyze endothelial function.
RESULTS: Type D personality was associated with decreased FMD across baseline, 3 months, and 12 months (mixed model analysis, p = 0.04), after adjustment for clinical characteristics, exercise training and depression. There was no significant association between Type D and decreased EPCs (p = 0.07). Age and smoking were other significant correlates of FMD and EPCs. Using a FMD <5.5% cut-off, Type D patients more often had endothelial dysfunction at baseline (24/37 = 65%) than non-Type Ds (63/143 = 44%); OR = 3.03, 95% CI 1.04-8.80. This significant Type D effect was confirmed in prospective analyses of endothelial dysfunction at 12 months (OR = 3.43, 95% CI 1.01-11.64), and in subgroup analyses of male patients.
CONCLUSIONS: Type D personality was associated with impaired endothelial function in men with CAD. This association was robust across time, independent from depressive symptoms, and supports the notion that Type D has an adverse effect on cardiovascular health in patients with CAD.
Copyright © 2018 The Authors. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Coronary artery disease; Depression; Endothelial dysfunction; FMD; Type D personality

Mesh:

Year:  2018        PMID: 29477262     DOI: 10.1016/j.ijcard.2018.02.064

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  5 in total

1.  Negative affectivity and social inhibition are associated with increased cardiac readmission in patients with heart failure: A preliminary observation study.

Authors:  Tin-Kwang Lin; Kai-Xun You; Chiu-Tien Hsu; Yi-Da Li; Chin-Lon Lin; Chia-Ying Weng; Malcolm Koo
Journal:  PLoS One       Date:  2019-04-19       Impact factor: 3.240

2.  The Influence of Personality Type D on Cardiovascular Prognosis in Patients After Coronary Artery Bypass Grafting: Data from a 5-Year-Follow-up Study.

Authors:  Olga Igorevna Raykh; Alexei Nikolayevich Sumin; Ekaterina Victorovna Korok
Journal:  Int J Behav Med       Date:  2021-05-06

Review 3.  Endothelial Progenitor Cells: An Appraisal of Relevant Data from Bench to Bedside.

Authors:  Doralisa Morrone; Maria Elena Lucia Picoi; Francesca Felice; Andrea De Martino; Cristian Scatena; Paolo Spontoni; Antonio Giuseppe Naccarato; Rossella Di Stefano; Uberto Bortolotti; Massimo Dal Monte; Stefano Pini; Marianna Abelli; Alberto Balbarini
Journal:  Int J Mol Sci       Date:  2021-11-28       Impact factor: 5.923

4.  Type D Personality Associated With Increased Risk for Mortality in Adults With Congenital Heart Disease.

Authors:  Dirkjan Kauw; Dounya Schoormans; Gertjan Tj Sieswerda; Joost P Van Melle; Hubert W Vliegen; Arie P J Van Dijk; Mariët S Hulsbergen-Zwarts; Marco C Post; Tieneke J Ansink; Barbara J M Mulder; Berto J Bouma; Mark J Schuuring
Journal:  J Cardiovasc Nurs       Date:  2022 Mar-Apr 01       Impact factor: 2.083

Review 5.  Type D Personality as a Risk Factor in Coronary Heart Disease: a Review of Current Evidence.

Authors:  Nina Kupper; Johan Denollet
Journal:  Curr Cardiol Rep       Date:  2018-09-12       Impact factor: 2.931

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.